Core Viewpoint - The Clorox Company (NYSE:CLX) is facing mixed analyst sentiments, with price targets being adjusted downwards due to uncertainties in consumer staples, while some analysts remain optimistic about its growth potential through innovation and portfolio changes [2][3]. Group 1: Analyst Ratings and Price Targets - Bank of America analyst Anna Lizzul has lowered the price target for Clorox from $125 to $110, maintaining a Neutral rating, citing concerns over consumption growth in the consumer staples sector leading into 2026 [2]. - Jefferies has a more positive outlook, setting a price target of $102 based on a 26x multiple of its fiscal 2027 EPS estimate, highlighting the potential for growth through innovation and improved product mix [3]. Group 2: Company Performance and Metrics - Clorox shares have declined nearly 40% since the start of 2025, but the company's underlying performance has shown improvement since 2024, with revenue and profit trends stabilizing [4]. - A notable recovery in return on invested capital (ROIC) has been observed, now around 25%, indicating regained business discipline and efficiency [4]. Group 3: Company Overview - The Clorox Company is a US-based multinational that manufactures and markets consumer and professional products across cleaning, household, and lifestyle categories [5].
Bank of America Cuts Clorox (CLX) Target as Consumer Staples Face 2026 Uncertainty